These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


61 related items for PubMed ID: 1313734

  • 1. [Protective activity of monoacetone glucose 3-butyrate, prodrug of n-butyric acid, against the fatal effect of encephalomyocarditis virus in mice].
    Pouillart P, Cerutti I, Ronco G, Villa P, Chany C.
    C R Acad Sci III; 1992; 314(2):49-54. PubMed ID: 1313734
    [Abstract] [Full Text] [Related]

  • 2. Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon.
    Pouillart P, Cerutti I, Ronco G, Villa P, Chany C.
    Int J Cancer; 1992 Jun 19; 51(4):596-601. PubMed ID: 1318271
    [Abstract] [Full Text] [Related]

  • 3. Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line.
    Calabresse C, Venturini L, Ronco G, Villa P, Chomienne C, Belpomme D.
    Biochem Biophys Res Commun; 1993 Aug 31; 195(1):31-8. PubMed ID: 8363611
    [Abstract] [Full Text] [Related]

  • 4. Low level toxicity and antitumor activity of butyric mono- and polyester monosaccharide derivates in mice.
    Pouillart P, Ronco G, Cerutti I, Chany C, Villa P.
    J Biol Regul Homeost Agents; 1990 Aug 31; 4(4):135-41. PubMed ID: 2096598
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of butyric acid derivative with xylitol.
    Desmet G, Brazier M, Cerutti J, Chany C, Arnould-Guerin ML.
    Eur J Drug Metab Pharmacokinet; 1991 Aug 31; Spec No 3():348-51. PubMed ID: 1820907
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy.
    Pouillart P, Cerutti I, Ronco G, Villa P, Chany C.
    Int J Cancer; 1991 Aug 19; 49(1):89-95. PubMed ID: 1874576
    [Abstract] [Full Text] [Related]

  • 11. Butyrate inhibits mouse fibroblasts at a control point in the G1 phase.
    Wintersberger E, Mudrak I, Wintersberger U.
    J Cell Biochem; 1983 Aug 19; 21(3):239-47. PubMed ID: 6195168
    [Abstract] [Full Text] [Related]

  • 12. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
    Chen ZX, Breitman TR.
    Cancer Res; 1994 Jul 01; 54(13):3494-9. PubMed ID: 8012972
    [Abstract] [Full Text] [Related]

  • 13. [Inhibitory effect of sodium butyrate on the in vitro growth of Herpes virus hominis, type I].
    Daniel P, Pieri F.
    C R Acad Sci III; 1985 Jul 01; 300(7):251-3. PubMed ID: 2986799
    [Abstract] [Full Text] [Related]

  • 14. Effect of n-butyrate on superinfection of Raji lymphoblastoid cell line by Epstein-Barr virus.
    Roubal J, Roubalová K.
    Acta Virol; 1985 Mar 01; 29(2):162-5. PubMed ID: 2860802
    [Abstract] [Full Text] [Related]

  • 15. Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells.
    Takenaga K.
    Cancer Res; 1986 Mar 01; 46(3):1244-9. PubMed ID: 3943096
    [Abstract] [Full Text] [Related]

  • 16. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D, Nudelman A, Tarasenko N, Levovich I, Makarovsky I, Sochotnikov S, Tarasenko I, Rephaeli A.
    J Med Chem; 2008 Jan 24; 51(2):314-23. PubMed ID: 18163551
    [Abstract] [Full Text] [Related]

  • 17. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
    Laskay T, Kiessling R.
    Nat Immun Cell Growth Regul; 1986 Jan 24; 5(4):211-20. PubMed ID: 3095635
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
    Corin RE, Haspel HC, Peretz AM, Sonenberg M, Rifkind RA.
    Cancer Res; 1986 Mar 24; 46(3):1136-41. PubMed ID: 3455880
    [Abstract] [Full Text] [Related]

  • 20. Histone H1 in nuclei of butyrate-treated murine lymphosarcoma cells has increased affinity for heparin.
    Stros M, Siroký J.
    Gen Physiol Biophys; 1985 Aug 24; 4(4):375-81. PubMed ID: 3839761
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.